Dabrafenib,Trametinib
Novartis
['basket study', 'trametinib', 'roar', 'dabrafenib']
 hot off the press ! just in time for #aacr23 our practice changing roar basket study that led to the tissue agnostic approval of dabrafenib+ trametinib in braf v600e positive tumors is publihsed in ! a huge win for patients with these rare 
Oncologist | Associate Prof | Executive Director-Research, MD Anderson Cancer Network | Medical Director, Clinical Center for Targeted Therapy. Tweets = my own.